Advancing medicine through technology transfer, 75+ molecules, and AI-powered regulatory intelligence.
Burrard Pharmaceuticals is a Vancouver-based Contract Development and Manufacturing Organization (CDMO), delivering world-class technology transfer, formulation development, and regulatory services since 2005.
We combine deep scientific expertise with AI-powered intelligence to accelerate your path to market — across biosimilars, oncology injectables, diabetes, respiratory, and emerging therapeutic areas.
Learn More About UsEnd-to-end pharmaceutical services powered by Burrard Intelligence.
Seamless transfer of manufacturing processes, analytical methods, and regulatory documentation for 75+ molecules.
AI-assisted formulation optimization for small molecules, biologics, and complex generics.
Complete CTD/eCTD preparation with unlimited templates through Burrard Intelligence subscription.
GMP-compliant manufacturing for injectables, oral solids, ophthalmics, and topicals.
Subscribe to Burrard Intelligence for unlimited CTD/eCTD template requests, 48-hour delivery, monthly regulatory reports, and priority expert advisory services.
Any module, any molecule — backed by 20+ years of pharmaceutical expertise and AI-powered insights.
Spanning oncology, diabetes, respiratory, immunology, cardiovascular, and ophthalmics.
Trastuzumab, Bevacizumab, Rituximab, Pembrolizumab biosimilars, Paclitaxel, Docetaxel, Carboplatin, and more.
Semaglutide, Tirzepatide, Liraglutide, Dulaglutide, Insulin Glargine, Insulin Aspart, and more.
Dupilumab, Omalizumab, Secukinumab, Ustekinumab, Fluticasone combinations, and more.
Every product meets the highest standards of pharmaceutical quality. Our facilities are equipped for sterile injectables, complex generics, and next-generation therapeutics.
Partner With Us